Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
Rhea-AI Summary
Bioventus (Nasdaq:BVS) announced that Senior Vice-President and CFO Mark Singleton will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at 4:00 p.m. ET.
A live webcast and replay will be available in the Investors section of the Bioventus website.
Positive
- None.
Negative
- None.
News Market Reaction – BVS
In the Jun 2 session, BVS gained 2.27%, reflecting a moderate positive market reaction. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 06 | Earnings results | Positive | +2.3% | Q1 2026 results with revenue growth and raised EPS and cash guidance. |
| Apr 28 | Earnings date | Neutral | -2.9% | Announcement of date and webcast details for Q1 2026 earnings call. |
| Mar 05 | Earnings results | Positive | +7.4% | Q4 and full-year 2025 results with adjusted EBITDA growth and 2026 guidance. |
| Feb 24 | Earnings date | Neutral | +0.3% | Notification of Q4 2025 earnings release date and investor call logistics. |
| Jan 06 | Conference appearance | Neutral | +1.1% | CEO presentation at J.P. Morgan Healthcare Conference with webcast and replay. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent fundamentally positive earnings reports and conference appearances have generally coincided with positive or modestly positive price reactions.
Over the past six months, Bioventus has reported improving fundamentals, including Q4 2025 and Q1 2026 results with revenue growth, profitability, and raised 2026 guidance, which saw 24-hour moves of 7.44% and 2.25%. Earnings-date notices and a prior conference appearance around Jan 6, 2026 had smaller reactions between about 0.34% and 1.06%. Today’s conference participation announcement fits the pattern of routine investor-relations communication alongside a backdrop of strengthening financial performance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026, at 4:00 p.m. ET.
A live webcast of the presentation will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
